Infectious Disease Referrals Boston, MA - 02114

Infectious Disease Referrals is categorized under Infectious Disease Specialists in Boston, MA and active since 1994.

Infectious Disease Referrals was established in 1994, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Dr Stephen Calderwood at the company’s single location by writing to 15 Parkman St, Boston, Massachusetts MA 02114 or by phoning (617) 726-3906. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Infectious Disease Referrals
Contact Person: Dr Stephen Calderwood
Address: 15 Parkman St, Boston, Massachusetts 02114
Phone Number: (617) 726-3906
Annual Revenue (USD): $100.000 to $499.999
Founded: 1994
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Infectious Disease Specialists
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Infectious Disease Referrals was started in 1994 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Dr Stephen Calderwood for inquiries that concern Infectious Disease Referrals by calling the company number (617) 726-3906, as your correspondence is most welcome. Additionally, the physical location of the single location of Infectious Disease Referrals can be found at the coordinates 42.362296,-71.068394 as well as the street address 15 Parkman St in Boston, Massachusetts 02114.

For its online presence, you may visit Infectious Disease Referrals’s website at and engage with its social media outlets through on Twitter and on Facebook.